European equities traded in the US as American depositary receipts were trending higher late Monday morning, rising 0.76% to 1,450.21 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by furniture manufacturer Natuzzi (NTZ) and accommodations booking company trivago (TRVG), which advanced 23% and 10%, respectively. They were followed by biopharmaceutical companies DBV Technologies (DBVT) and Cellectis (CLLS), which were up 3.4% and 2.7%, respectively.

The only decliners from continental Europe were petroleum refiner Equinor (EQNR) and consumer goods company Unilever (UL), which were down 0.7% and 0.6%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana (NCNA) and biotech firm Trinity (TRIB), which shed 10% and 9.4%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and tobacco company British American Tobacco (BTI), which rose 4.9% and 2.6%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and pharmaceutical company Silence Therapeutics (SLN), which dropped 7.2% and 1.8%, respectively. They were followed by biopharmaceutical company Amarin (AMRN) and communications company WPP (WPP), which fell 1.7% and 0.9%, respectively.